NASDAQ:ENLV   ENLIVEX THERAPEUTICS LTD
The drug Allocetra saves the lives of patients in a severe condition from the virus in Israel.
The end of the Phase 2 trial is about to be published soon.
preventing or treating complications associated with sepsis, COVID-19, bone-marrow transplants and solid tumors.
At the end of 2021, the drug report on patients will be published.
Last chance before takeoff.
Opinion only not a professional recommendation.

Comments

Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Private Messages Chat Sign Out